Tranexamic acid versus Misoprostol in reducing blood loss during cesarean section: a cross-sectional comparative study in Abakaliki, Nigeria

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910644489698

Enrollment

358

Registered

2019-10-17

Start date

2017-01-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Misoprostol

tranexamic acid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Booked women Elective cesearean section

Exclusion criteria

Exclusion criteria: Previous cesarean section Hypertensive disorders of pregnancy Known allergy to misoprostol or tranexamic acid Antepartum haemorrhage Emergency caesarean section Bleeding disorder

Design outcomes

Primary

Measure	Time frame
Primary outcome: Quantity of blood loss during ceserean section	—

Secondary

Measure	Time frame
Secondary outcome: Need for blood transfusion Need for additional intervention to control blood loss Change in haemoglobin concentration 48hours after surgery Change systemic blood pressure 4 hours after surgery	—

Countries

Nigeria

Contacts

Public Contactanikwe chidebe christian

consultant dept of OBYGN abakaliki

drchideanikwechristian@gmail.com+2348064165965

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026